The FDA grants Priority Review to medicines that, if approved, have the potential to offer significant improvement compared to marketed products or... ...
http://www.moneycontrol.com/news/business/celgene-announces-usfda-grants-priority-review-for-abraxane_879532.htmlEMA validates Gilead's MAA for sofosbuvir for hepatitis C treatment Foster City, California The European Medicines Agency (EMA) has validated... ...
http://www.pharmabiz.com/NewsDetails.aspx?aid=75513&sid=2Evolutionary Medical Device Comes to the Aid of Millions Suffering from Psoriasis, Eczema, & Vitiligo PR Newswire SCHAUMBURG, Ill., May 22, 2013... ...
http://www.asianhhm.com/news/news_archives.asp?NewsID=46089&title=WCUIaposs-PsoriaShield®-Announces-Sales-RollOut-of-PsoriaLight®-to-Key-MarketsJanssen R&D Ireland (Janssen), a partner of Medivir AB, has published the primary efficacy and safety results from the global phase III study... ...
http://www.pharmabiz.com/NewsDetails.aspx?aid=75501&sid=2--Pfizer to offer remaining Zoetis stake in exchange to Pfizer shareholders --Pfizer sold about 20% of Zoetis in February IPO --Pfizer sees... ...
http://in.advfn.com/p.php?pid=nmona&article=57691778European Union Agency
0 Followers
European Union Agency
0 Followers
European Union Agency
0 Followers
European Union Agency
0 Followers